Tocilizumab reverses cerebral vasculopathy in a patient with homozygous SAMHD1 mutation

Henrickson M, Wang H. Tocilizumab reverses cerebral vasculopathy in a patient with homozygous SAMHD1 mutation. Clin Rheumatol. 2017 Mar 13. doi: 10.1007/s10067-017-3600-2. [Epub ahead of print] Review.